Compare OSCR & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OSCR | RGEN |
|---|---|---|
| Founded | 2012 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Accident &Health Insurance | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 6.6B |
| IPO Year | 2021 | 1995 |
| Metric | OSCR | RGEN |
|---|---|---|
| Price | $28.19 | $131.96 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 8 | 12 |
| Target Price | $16.88 | ★ $167.67 |
| AVG Volume (30 Days) | ★ 4.7M | 1.1M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 286.96 |
| EPS | ★ 2.07 | 0.15 |
| Revenue | ★ $11,701,427,000.00 | $141,236,000.00 |
| Revenue This Year | $63.89 | $14.30 |
| Revenue Next Year | $5.30 | $14.52 |
| P/E Ratio | ★ $14.02 | $917.33 |
| Revenue Growth | 27.50 | ★ 35.10 |
| 52 Week Low | $10.69 | $100.99 |
| 52 Week High | $33.10 | $175.77 |
| Indicator | OSCR | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 46.80 | 44.43 |
| Support Level | $27.89 | $127.63 |
| Resistance Level | $32.71 | $141.46 |
| Average True Range (ATR) | 1.59 | 6.48 |
| MACD | -0.50 | -1.76 |
| Stochastic Oscillator | 10.53 | 24.02 |
Oscar Health Inc is a healthcare technology company built around a full stack technology platform and a relentless focus on serving its members. It offers Individual & Family plans and health technology solutions that power the healthcare industry. Oscar operates as one segment to sell insurance to individuals, families and employees through the federal and state-run healthcare exchanges formed in conjunction with the Patient Protection and Affordable Care Act (ACA) and leverages its technology platform to provide services via its Oscar offering.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.